Results 121 to 130 of about 10,263 (254)

The Neuroleptic Malignant Syndrome: Do we Know Enough? [PDF]

open access: yes, 2011
The Neuroleptic Malignant Syndrome (NMS) is a potentially grave adverse reaction to oral or parenteral neuroleptic therapy that may be an underdiagnosed and easily overlooked clinical problem.
Ali, MD, Ali Hassan M.
core   +1 more source

Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group [PDF]

open access: yes, 2017
Survival from a malignant hyperthermia (MH) crisis is highly dependent on early recognition and prompt action. MH crises are very rare and an increasing use of total i.v.
Ellis, F. R.   +6 more
core  

Post-Anesthesia Cognitive Dysfunction in Mice Is Associated with an Age-Related Increase in Neuronal Intracellular [Ca2+]—Neuroprotective Effect of Reducing Intracellular [Ca2+]: In Vivo and In Vitro Studies

open access: yesCells
Background: Postoperative cognitive dysfunction (POCD) is a common disorder after general anesthesia in elderly patients, the precise mechanisms of which remain unclear.
Arkady Uryash   +5 more
doaj   +1 more source

Molecular genetic analysis for malignant hyperthermia : a thesis presented to Massey University in partial fulfilment of the requirements for the degree of Master of Science in Biochemistry [PDF]

open access: yes, 2004
Malignant hyperthermia (MH) is a rare pharmacogenetic disorder in humans caused by inhalational general anaesthetics and depolarising muscle relaxants. An MH reaction shows abnormal calcium homeostasis in skeletal muscle leading to a hypermetabolic state
Sato, Keisaku
core  

Transient transfection induces different intracellular calcium signaling in CHO K1 versus HEK 293 cells [PDF]

open access: yes, 2018
For the controlled production of recombinant proteinsin mammalian cells by transient transfection, it maybe desirable not only to manipulate, but also todiagnose the expression success early.
Connor, J., Preuss, A., Vogel, H.
core  

Diagnosis in the Neuroleptic Malignant Syndrome [PDF]

open access: yes, 2011
Neuroleptic malignant syndrome (NMS) is an uncommon, potentially lethal complication of treatment with antipsychotic medication. First described in American journals by Delay and Deniker in 1968 (1), this syndrome has been reported for many years in the ...
Dallman, MD, CPT, MC, James H.
core   +1 more source

Home - About - Disclaimer - Privacy